Trial Details
TERMINATEDBasic Information
| Clinical ID | c2020 |
|---|---|
| Identifier | NCT04102111 |
| Trial Title | A Study Evaluating Participants With Moderately to Severely Active Crohn's Disease |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Crohn Disease |
| Interventions | DRUG: JNJ-67864238|DRUG: Placebo |
Participant Information
| Sponsor | Janssen Research & Development, LLC |
|---|---|
| City | Colorado Springs |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2019-09-23 |
|---|---|
| Primary Completion Date | 2021-11-17 |
| Completion Date | 2021-12-22 |